21 August 2017
Reading, United Kingdom (21 August 2017) – Convatec Group Plc (“Convatec” or “the Company”) announces the appointment of Donal Balfe as Executive Vice President Global Operations and member of the Executive Committee of the Company, with effect from 1 October 2017.
Since 2009, Donal has been Vice President of Operations for Medtronic PLC, where he was responsible for 13 manufacturing sites comprising the European and Asian manufacturing operations and the Renal Care Solutions business unit of Medtronic’s MITG group. In this role, Donal supervised continuous change actions to improve service and business performance, reduce costs, enhance quality and increase margins, within a regulated environment. He has also led programmes to consolidate manufacturing operations and implement Six Sigma and Lean manufacturing initiatives.
Prior to joining Medtronic, Donal was Vice President of Manufacturing at Covidien. He has 29 years of experience in Medical Device manufacturing, having started his career with Bayer Corporation.
Paul Moraviec, Chief Executive Officer of Convatec, said:
“I am delighted to announce Donal’s appointment to lead our manufacturing operations and the execution of our Margin Improvement Programme. He brings exceptional experience of the Medical Technology sector and operational management to our Company and I look forward to working with him to deliver on the targets that we have set ourselves.”
Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Convatec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com
Analysts and Investors
John Crosse, VP Investor Relations, Convatec +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, Convatec +44 (0)7470 909 582
Bobby Leach, VP Group Corporate Affairs, Convatec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Organisation AppointmentsRead more
FY2017 guidance and third quarter updateRead more
Convatec Introduces GentleCath™ Glide and me+™ Continence Care Programme for Intermittent Catheter Users in EuropeRead more
Scrip DividendRead more
Appointment to Executive CommitteeRead more
Convatec appoints two Non-Executive DirectorsRead more
Convatec Launches Natura™ Convex Accordion Flange™, Designed to Make Ostomy Pouch Application Easier and More ComfortableRead more
Convatec Announces 2017 Interim resultsRead more
03 August 2017 - Board ChangesRead more
Convatec Announces Acquisition of Woodbury HoldingsRead more
Announcement on Board of DirectorsRead more